These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 15941926

  • 1. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 2. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 3. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 4. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 5. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cortisol in dried blood screening specimens from newborns with raised 17-hydroxyprogesterone and congenital adrenal hyperplasia.
    Mitchell ML, Hermos RJ.
    Clin Endocrinol (Oxf); 1998 Jun 17; 48(6):757-60. PubMed ID: 9713565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M, Dauerer E, DiRienzo AG, Caggana M, Tavakoli NP.
    Eur J Pediatr; 2017 Jan 17; 176(1):121-129. PubMed ID: 27900477
    [Abstract] [Full Text] [Related]

  • 11. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul 17; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 12. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q, Wang B, Chen Y, Jiang D, Chen Y.
    Zhonghua Er Ke Za Zhi; 2014 Sep 17; 52(9):706-9. PubMed ID: 25476436
    [Abstract] [Full Text] [Related]

  • 13. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A, Wedell A, Hagenfeldt L, Marcus C, Larsson A.
    Pediatrics; 2001 Oct 17; 108(4):E68. PubMed ID: 11581476
    [Abstract] [Full Text] [Related]

  • 14. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R.
    Pediatr Res; 2004 Nov 17; 56(5):701-5. PubMed ID: 15371568
    [Abstract] [Full Text] [Related]

  • 15. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
    Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct 26; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
    Török D, Eckhardt G, Sólyom J.
    Eur J Pediatr; 2003 Dec 26; 162(12):844-9. PubMed ID: 14648216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.